Insights
Media Center
Latest Therapy Updates
- Science Bulletin│Shanghai Institute of Materia Medica developed a tumor-targeted lipoplex to generate in situ NKG2D CAR T/NK cells to enhance tumor immunotherapy
- Opening the “Black Box” of Liver Cancer Metastasis to the Lungs: Fudan Team’s Findings Published in Science
- Sichuan Kelun Pharmaceutical Co., Ltd.’s announcement that the subsidiary’s core product TROP2 ADC sacituzumab tirumotecan (sac-TMT)’s marketing application for new indications has been accepted by the National Medical Products Administration
- Boao Lecheng expands its biomedical technology programmes
- World’s First Approved Bispecific ADC Izalontamab Brengitecan for Injection Now Available at Jiahui International Cancer Center
Page 3 of 12
What could this mean for your care?
A promising treatment raises a personal question: could it be an option for you? Chirona helps you explore that question with the right specialists.
Start a case reviewHow our service worksUnderstand your options
Explore the treatments relevant to your diagnosis, previous care and priorities.
Bring your case to specialists
We help organise your medical records and coordinate a professional assessment of suitability and access.
Plan the next step together
If a treatment path is appropriate, we help coordinate consultations, hospital arrangements and continuity of care.